PERKINELMER Stock Price, News & Analysis

PKI historically referred to PerkinElmer, a company described as enabling scientists, researchers, and clinicians to address critical challenges across science and healthcare. According to available information, the company focused on serving the diagnostics, life sciences, food, and applied markets. It is classified in the analytical laboratory instrument manufacturing industry within the broader manufacturing sector.

The description indicates that PerkinElmer’s mission was centered on "innovating for a healthier world." It states that the company delivered solutions for customers working in areas such as diagnostics and life sciences, and that it partnered with customers to enable earlier and more accurate insights. The information also notes that the organization relied on technical expertise and market knowledge to support its activities in these markets.

The available profile further states that PerkinElmer served customers in many countries and was included in the S&P 500 index. It also notes that the company had a large global workforce and that its employees were described as being focused on helping customers work toward healthier families, improved quality of life, and sustaining wellbeing and longevity for people globally.

While more recent news flow and financial reporting relate to Revvity, Inc. (NYSE: RVTY), the PKI symbol is historically associated with PerkinElmer. The current data provided does not include specific SEC filings under PKI, nor does it detail the precise corporate steps that led from PerkinElmer to Revvity. As a result, PKI is best understood here as a historical ticker linked to PerkinElmer’s role in analytical laboratory instruments and related health science markets, based on the legacy description available.

Business focus and markets served

According to the legacy description, PerkinElmer focused on solutions that supported diagnostics and life sciences, as well as food and applied markets. These references suggest that its activities were oriented toward scientific and healthcare applications where analytical instruments and related technologies are central to customer workflows. The description emphasizes enabling earlier and more accurate insights, which aligns with the role of analytical laboratory instruments in measurement, detection, and analysis.

The same description notes that PerkinElmer worked with scientists, researchers, and clinicians. This indicates that its customer base included organizations and professionals involved in research, clinical work, and other scientific applications. However, the available information does not break down specific product lines or detailed revenue streams beyond these broad market areas.

Position within the S&P 500 and global reach

The profile states that PerkinElmer was a component of the S&P 500 index and served customers in a large number of countries. Being part of the S&P 500 indicates that, at the time of that description, the company was considered a large-cap U.S. issuer. The reference to customers across many countries highlights an international footprint, although no specific regions or countries beyond that count are provided in the source.

The information also notes that PerkinElmer had a sizable workforce. This reinforces the characterization of the company as a large, established participant in analytical laboratory instrument manufacturing and related health science markets.

Relationship to Revvity (RVTY)

The recent news and financial information provided in the input relate to Revvity, Inc. (NYSE: RVTY). These news releases describe Revvity as providing health science solutions, technologies, expertise, and services that deliver workflows from discovery to development, and diagnosis to cure. They also state that Revvity focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics, and that it is part of the S&P 500 index with customers in more than 160 countries.

The coexistence of a historical PerkinElmer description under PKI and current Revvity news under RVTY in the provided data indicates a corporate evolution, but the specific legal steps and dates are not detailed in the sources here. Therefore, this overview treats PKI as a historical reference point tied to PerkinElmer, while acknowledging that current operations and disclosures are presented under Revvity’s RVTY symbol in the supplied news.

Investor considerations based on available information

From the information provided, an investor researching PKI can observe that the historical description for PerkinElmer and the current description for Revvity both emphasize health science–related activities, including diagnostics and life sciences. Both descriptions also reference membership in the S&P 500 index and a broad international customer base. However, without specific SEC filings or explicit corporate transaction details in the input, further conclusions about the exact transition from PKI to RVTY cannot be drawn here.

Users interested in the present-day business operations, financial results, and product announcements referenced in the news items should note that these are reported under Revvity, Inc. (NYSE: RVTY). The PKI page therefore serves primarily as a historical lens on PerkinElmer’s role in analytical laboratory instrument manufacturing and its stated mission in science and healthcare, based on the legacy description provided.